文献速递乳腺癌胸部肿瘤支持与姑息治疗

2020年全球癌症统计:GLOBOCAN对185个国家36种癌症发病与死亡的估计

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
PubMed 文献 · CA Cancer J Clin · 2021-02-04

该文基于国际癌症研究机构GLOBOCAN 2020估计,更新全球癌症负担。女性乳腺癌超过肺癌成为最常诊断癌症,肺癌仍为癌症死亡首位。

要点

  • 女性乳腺癌超过肺癌成为最常诊断癌症,肺癌仍为癌症死亡首位。

核心结论

  • 女性乳腺癌已超过肺癌成为全球最常诊断癌症,但肺癌仍是癌症死亡首位。

研究设计与样本

  • 基于国际癌症研究机构GLOBOCAN 2020对全球185个国家36种癌症发病与死亡的估计。

主要发现

  • 转型国家女性乳腺癌和宫颈癌死亡率显著高于转型后国家(每10万分别为15.0对12.8和12.4对5.2)。

关键数值与推荐

  • 转型国家女性乳腺癌和宫颈癌死亡率每10万分别为15.0对12.8和12.4对5.2。

临床怎么用

  • 应重视女性乳腺癌和宫颈癌在转型国家的死亡率差异,加强预防措施和癌症照护的基础设施建设。
  • 全球癌症负担预计2040年显著上升,需关注人口变化和风险因素增加对癌症控制的挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021. PMID: 33538338. doi:10.3322/caac.21660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。